Tenders/DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award

Open🇺🇸United StatesGrants

DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award

Dept. of the Army -- USAMRAA

Published: May 4, 2026

Updated: Jun 20, 2026

Source: grants_gov

About This Opportunity

Dept (United States) seeks grant funding — DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical. healthcare. Submission deadline Sep 2026.

This is a grants contract in the health and medical services and Research sectors, with a focus on Pharmaceuticals. Located in United States, North America, this opportunity is open to firms and consortiums. Proposals must be submitted before September 30, 2026.

Published through Grants.gov, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for grants in the health and medical services sector. Grant applications generally require a detailed project proposal, a clear results framework, and evidence of the applicant's capacity to deliver the proposed activities. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award (PCTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of amyotrophic lateral sclerosis (ALS). Projects may range from phase 1 to small-scale phase 2 trials.

Applications must address one of the following focus areas:
· Biomarker-Driven Interventions: Disease-modifying interventions, with mechanism-specific biomarkers to predict which clinical trial participants are likely to respond, demonstrate target engagement, and effects on the intended biological pathway. · Clinical Care: Improving aspects of clinical care and symptom management for ALS.
Distinctive Features: Funding from this award mechanism must support a clinical trial. The clinical trial should begin no later than 12 months after the award date or 18 months for U.S. Food and Drug Administration (FDA)-regulated studies.
Projects proposing a therapeutic intervention (drug, biologic, and/or device) must incorporate biomarkers specific to the intervention into the trial design.
All pre-applications and applications are required to incorporate community collaboration, as described in Section 3.2.2, to optimize research impact.

Applications must include a detailed Regulatory Strategy plan that outlines the approach for obtaining regulatory approvals, if required, specifically for the funded portion of the study. In addition, applications must provide a separate Transition Plan that describes how the outcomes of the study will be advanced to the next phase of development, beyond the scope of the funded work.

Agency: Jamie Shortall
Grant Officer

CFDA: 12.420

Applicant Types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Cost Sharing: No

Contact: Jamie Shortall
Grant Officer

Email: help@eBRAP.org

Data provenance

This notice is sourced from Grants.gov and was originally published on May 4, 2026. Last refreshed 3 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dept. of the Army -- USAMRAA

Dept. of the Army -- USAMRAA has issued 77 procurement notices on BidsFactory, including 77 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for United States. Notices are distributed via Grants.gov. Most recent publication: June 17, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit Grants.gov to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 30, 2026. You have 98 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by Dept. of the Army -- USAMRAA in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Grants contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.